Literature DB >> 25851770

Delayed Administration of Tat-HA-NR2B9c Promotes Recovery After Stroke in Rats.

Hai-Hui Zhou1, Ying Tang1, Xin-Yong Zhang1, Chun-Xia Luo1, Li-Yan Gao1, Hai-Yin Wu1, Lei Chang1, Dong-Ya Zhu2.   

Abstract

BACKGROUND AND
PURPOSE: Previous studies reported that Tat-NR2B9c, a peptide disrupting the N-methyl-d-aspartate receptor-postsynaptic density protein-95 interaction, reduced ischemic damage in the acute phase after stroke. However, its effect in the subacute phase is unknown. The aim of this study is to determine whether disrupting the N-methyl-d-aspartate receptor-postsynaptic density protein-95 interaction in the subacute phase promotes recovery after stroke.
METHODS: Studies were performed on Sprague-Dawley rats or nNOS(-/-) mice, and experimental ischemic stroke was induced by middle cerebral artery occlusion. Animals were treated with drugs starting at day 4 after ischemia. Sensorimotor functions and spatial learning and memory ability were assessed after drug treatment. Then, rats were euthanized for morphological observation and biochemical tests.
RESULTS: Disrupting the N-methyl-d-aspartate receptor-postsynaptic density protein-95 interaction with Tat-HA-NR2B9c significantly ameliorated the ischemia-induced impairments of spatial memory and sensorimotor functions in rats during subacute stage but did not improve stroke outcome in nNOS(-/-) mice. Consistent with the functional recovery, Tat-HA-NR2B9c substantially increased neurogenesis in the dentate gyrus and dendritic spine density of mature neurons in the motor cortex of rats, meanwhile, reversed the ischemia-induced formation of S-nitrosylation-cyclin-dependent kinase 5 and increased cyclin-dependent kinase 5 activity in ipsilateral hippocampus. However, directly blocking N-methyl-d-aspartate receptors with MK-801 or Ro 25-6981 did not show the beneficial effects above.
CONCLUSIONS: Dissociating N-methyl-d-aspartate receptor-postsynaptic density protein-95 coupling by Tat-HA-NR2B9c in the subacute phase after stroke promotes functional recovery, probably because of that it increases neurogenesis and dendritic spine density of mature neurons via regulating cyclin-dependent kinase 5 in the ischemic brain.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  Tat-NR2B9c; cyclin-dependent kinase 5; nitrosation; regeneration; stroke

Mesh:

Substances:

Year:  2015        PMID: 25851770     DOI: 10.1161/STROKEAHA.115.008886

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  17 in total

1.  Effects of Dimeric PSD-95 Inhibition on Excitotoxic Cell Death and Outcome After Controlled Cortical Impact in Rats.

Authors:  Jens Bak Sommer; Anders Bach; Hana Malá; Mikko Gynther; Ann-Sofie Bjerre; Marie Gajhede Gram; Linda Marschner; Kristian Strømgaard; Jesper Mogensen; Darryl S Pickering
Journal:  Neurochem Res       Date:  2017-08-21       Impact factor: 3.996

Review 2.  Pharmacological Enhancement of Stroke Recovery.

Authors:  Amit Kumar; Tomoko Kitago
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-30       Impact factor: 5.081

3.  Opening a New Time Window for Treatment of Stroke by Targeting HDAC2.

Authors:  Yu-Hui Lin; Jian Dong; Ying Tang; Huan-Yu Ni; Yu Zhang; Ping Su; Hai-Ying Liang; Meng-Cheng Yao; Hong-Jin Yuan; Dong-Liang Wang; Lei Chang; Hai-Yin Wu; Chun-Xia Luo; Dong-Ya Zhu
Journal:  J Neurosci       Date:  2017-06-07       Impact factor: 6.167

Review 4.  Pharmacological approaches promoting stem cell-based therapy following ischemic stroke insults.

Authors:  Shu-Zhen Zhu; Vivian Szeto; Mei-Hua Bao; Hong-Shuo Sun; Zhong-Ping Feng
Journal:  Acta Pharmacol Sin       Date:  2018-04-19       Impact factor: 6.150

5.  A novel cell-penetrating peptide protects against neuron apoptosis after cerebral ischemia by inhibiting the nuclear translocation of annexin A1.

Authors:  Xing Li; Lu Zheng; Qian Xia; Lu Liu; Meng Mao; Huijuan Zhou; Yin Zhao; Jing Shi
Journal:  Cell Death Differ       Date:  2018-05-16       Impact factor: 15.828

6.  Efficacy of the PSD95 inhibitor Tat-NR2B9c in mice requires dose translation between species.

Authors:  Lucy M Teves; Hong Cui; Michael Tymianski
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-19       Impact factor: 6.200

7.  Prolonged Use of NMDAR Antagonist Develops Analgesic Tolerance in Neuropathic Pain via Nitric Oxide Reduction-Induced GABAergic Disinhibition.

Authors:  Jun Li; Lin Zhang; Chu Xu; Yu-Hui Lin; Yu Zhang; Hai-Yin Wu; Lei Chang; Ying-Dong Zhang; Chun-Xia Luo; Fei Li; Dong-Ya Zhu
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

8.  The R18 Polyarginine Peptide Is More Effective Than the TAT-NR2B9c (NA-1) Peptide When Administered 60 Minutes after Permanent Middle Cerebral Artery Occlusion in the Rat.

Authors:  D Milani; N W Knuckey; R S Anderton; J L Cross; B P Meloni
Journal:  Stroke Res Treat       Date:  2016-05-10

9.  The role of postsynaptic density proteins in neural degeneration and regeneration.

Authors:  Yukti Vyas; Johanna M Montgomery
Journal:  Neural Regen Res       Date:  2016-06       Impact factor: 5.135

10.  Mice and Rats Exhibit Striking Inter-species Differences in Gene Response to Acute Stroke.

Authors:  Qiu Jing Wu; Xiujun Sun; Lucy Teves; Diana Mayor; Michael Tymianski
Journal:  Cell Mol Neurobiol       Date:  2021-08-05       Impact factor: 4.231

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.